BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Consumer Health

Thermo Fisher Scientific Joins Strategic Partnership to Advance Healthcare Innovation in Abu Dhabi

On the sidelines of its participation at Arab Health 2024, the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the ...

February 07, 2024 | News

Jiva.AI and Aevice Health Partner to Advance Medical AI for Asthma Prediction Using FDA-Cleared Remote Patient Monitor

The collaboration represents a synergistic blend of Jiva.ai's cutting-edge AI capabilities and Aevice Health's expertise in developing a proprietary ...

February 06, 2024 | News

Lumosa Therapeutics and CHI Memorial initiate a new Acute Stroke Study in Taiwan

Stroke, a leading cause of adult disability globally, hits particularly hard in Chattanooga, Tenn., an area known as the "Stroke Belt," with one of th...

February 02, 2024 | News

NADclinic Group and DISC Collaborate for Advanced Health in the Middle East

NADclinic's Groundbreaking IV Protocols Now in the Middle East NADclinic Group is a revolutionary health and wellness organisation, specialising in the pr...

January 26, 2024 | News

Japan greenlights historic treatment for ultra-rare Progeria, marking a significant breakthrough in addressing rapid-aging diseases.

The Progeria Research Foundation (PRF) today announced a new milestone with the approval of Zokinvy™ (lonafarnib) by the Japanese Ministry of Health,...

January 22, 2024 | News

Inceptua announces a Free Goods Programme for patients with rare diseases

Inceptua Group (Inceptua) and Cycle Pharmaceuticals Ltd (Cycle) have announced a partnership to make NITYR® (nitisinone) Tablets available via a Free G...

January 20, 2024 | News

Cervical Cancer Screenings Drop Among Commercially Insured Women, Analysis Reveals Alarming Decline in Lifesaving Tests

The number of women getting recommended cervical cancer screenings is declining, according to data from Cedar Gate Technologies’ proprietary Nat...

January 18, 2024 | Analysis

Japan Approves Neurolief's Relivion®, Paving the Way for At-Home Migraine Treatment.

Relivion® is a novel, non-invasive multi-channel brain neuromodulation technology. It stands out by concurrently stimulating the occipital and tri...

January 12, 2024 | News

Singapore Ministry of Health Initiates Mandatory Tuberculosis Screening in Response to Identified Cluster

Whole genome sequencing (WGS) has revealed a closed genetic relatedness among cases linked to Blocks 1 and 3 Jalan Bukit Merah, ABC Brickworks Market and F...

January 08, 2024 | News

Glenmark Launches First Biosimilar of Liraglutide, a Popular Anti-Diabetic Drug in India

‐ The anti‐diabetic biosimilar has been launched under the brand name Lirafit™, and is indicated for improving glycemic control in adult ...

January 03, 2024 | News

Clover's SCB-219M Shows Positive Phase I Results for Chemotherapy-Induced Thrombocytopenia (CIT) Treatment

--All CIT patients maintained platelet counts >75 x 109/L at 1-week following chemotherapy plus a single dose of SCB-219M, with durable responses t...

December 29, 2023 | News

WHO Approves Second Malaria Vaccine, Signifying Key Prevention Milestone

The R21 vaccine is the second malaria vaccine prequalified by WHO, following the RTS,S/AS01 vaccine which obtained prequalification status in July 2022. Bo...

December 25, 2023 | News

Juniper Therapeutics Secures Exclusive SAR Registration Rights for COVID-19 Drug from Ping An-Shionogi HK in Singapore

Singapore-headquartered Juniper Therapeutix, a science-led healthcare company focused on commercializing novel therapies, announced its agreement with...

December 22, 2023 | News

Combatting Cancer Disparities: Addressing Challenges and Expanding Access to Care in Low- and Middle-Income Countries

In an exclusive email interview with BioPharma APAC, Carmen Auste, the CEO of Cancer Warriors Foundation Philippines and Vice President of Cancer Coalition...

December 13, 2023 | News

Stay Connected